US20170129838A1 - Bisphosphites having 2,4-dimethylphenyl units and use thereof as ligands in hydroformylation - Google Patents

Bisphosphites having 2,4-dimethylphenyl units and use thereof as ligands in hydroformylation Download PDF

Info

Publication number
US20170129838A1
US20170129838A1 US15/345,962 US201615345962A US2017129838A1 US 20170129838 A1 US20170129838 A1 US 20170129838A1 US 201615345962 A US201615345962 A US 201615345962A US 2017129838 A1 US2017129838 A1 US 2017129838A1
Authority
US
United States
Prior art keywords
substituted
alkyl
tbu
ome
substituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/345,962
Inventor
Katrin Marie Dyballa
Robert Franke
Dirk Fridag
Dieter Hess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Evonik Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Degussa GmbH filed Critical Evonik Degussa GmbH
Publication of US20170129838A1 publication Critical patent/US20170129838A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/17—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrogenation of carbon-to-carbon double or triple bonds
    • C07C29/177—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrogenation of carbon-to-carbon double or triple bonds with simultaneous reduction of a carboxy group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/141—Esters of phosphorous acids
    • C07F9/1411—Esters of phosphorous acids with hydroxyalkyl compounds with further substituents on alkyl
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/1616—Coordination complexes, e.g. organometallic complexes, immobilised on an inorganic support, e.g. ship-in-a-bottle type catalysts
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1845—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing phosphorus
    • B01J31/185—Phosphites ((RO)3P), their isomeric phosphonates (R(RO)2P=O) and RO-substitution derivatives thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C07C45/50—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C07C45/50—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
    • C07C45/505—Asymmetric hydroformylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/21—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0033—Iridium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0046—Ruthenium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0073—Rhodium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0073—Rhodium compounds
    • C07F15/008—Rhodium compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/06—Cobalt compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/141—Esters of phosphorous acids
    • C07F9/145—Esters of phosphorous acids with hydroxyaryl compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30—Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/32—Addition reactions to C=C or C-C triple bonds
    • B01J2231/321—Hydroformylation, metalformylation, carbonylation or hydroaminomethylation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0238—Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
    • B01J2531/0241—Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/821—Ruthenium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/822—Rhodium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/827—Iridium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/84—Metals of the iron group
    • B01J2531/845—Cobalt
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235—Nitrogen containing compounds
    • B01J31/0237—Amines

Definitions

  • the invention relates to bisphosphites having 2,4-dimethylphenyl units and a method for the preparation thereof. Furthermore, the invention relates to the use of the compounds as ligands in a ligand-metal complex.
  • the compound, and also the complex may be used as a catalytically active composition in hydroformylation reactions.
  • Phosphorus-containing compounds as ligands, play a crucial role in a multitude of reactions.
  • Said compounds include phosphite ligands, i.e., compounds comprising P—O bonds, used in hydrogenation, hydrocyanation and especially hydroformylation.
  • symmetric bisphosphites are prepared and used as ligands for hydroformylation.
  • the symmetric bisphosphite ligands used in the hydroformylation are prepared at low temperatures. Adherence to these low temperatures is absolutely necessary since according to these US documents higher temperatures would lead to rearrangements and ultimately to asymmetric bisphosphites.
  • One of the best catalysts at present for the hydroformylation of olefins is to use an asymmetrical bisphoshite as ligand, 4,8-di-tert-butyl-2,10-dimethoxy-6-((3,3′,5,5′-tetramethyl-2′-((2,4,8,10-tetramethyldibenzo[d,f][1,3,2]dioxa phosphepin-6-yl)oxy)-[1,1′-biphenyl]-2-yl)oxy)dibenzo[d,f][1,3,2] dioxaphosphepine.
  • This is characterized by a very good yield in combination with very good regioselectivity.
  • this ligand is very expensive to prepare due to its many synthetic stages. Since the price of ligands has an essential influence of the overall cost-effectiveness of a method, it is desirable to find alternative ligands with comparably good properties (yield and regioselectivity) but which are more cost-effective in terms of their preparation.
  • the technical object of the invention is the provision of a novel ligand which does not have the above-detailed disadvantages from the prior art in the hydroformylation of unsaturated compounds, but instead has the following properties:
  • the object is achieved by a compound according to claim 1 .
  • R 2 , R 3 , R 4 are selected from: —H, —(C 1 -C 12 )-alkyl, —O—(C 1 -C 12 )-alkyl, wherein the alkyl groups mentioned may be substituted as follows: substituted —(C 1 -C 12 )-alkyl groups and substituted —(C 1 -C 12 )-alkoxy groups, depending on their chain length, may have one or more substituents; the substituents are mutually independently selected from —(C 3 -C 12 )-cycloalkyl, —(C 3 -C 12 )-heterocycloalkyl, —(C 6 -C 20 )-aryl, fluorine, chlorine, cyano, formyl, acyl or alkoxycarbonyl.
  • —(C 1 -C 12 )-alkyl encompasses straight-chain and branched alkyl groups. Preferably, these groups are unsubstituted straight-chain or branched —(C 1 -C 8 )-alkyl groups and most preferably —(C 1 -C 6 )-alkyl groups.
  • Examples of —(C 1 -C 12 )-alkyl groups are especially methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, 2-pentyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, 2-hexyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 2,2-dimethylbutyl, 1,3-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethylbutyl, 1-ethyl
  • —(C 1 -C 12 )-alkyl also apply to the alkyl groups in —O—(C 1 -C 12 )-alkyl, i.e. in —(C 1 -C 12 )-alkoxy.
  • these groups are unsubstituted straight-chain or branched —(C 1 -C 6 )-alkoxy groups.
  • Substituted —(C 1 -C 12 )-alkyl groups and substituted —(C 1 -C 12 )-alkoxy groups, depending on their chain length, may have one or more substituents; the substituents are mutually independently selected from —(C 3 -C 12 )-cycloalkyl, —(C 3 -C 12 )-heterocycloalkyl, —(C 6 -C 20 )-aryl, fluorine, chlorine, cyano, formyl, acyl or alkoxycarbonyl.
  • R 2 , R 3 , R 4 are selected from: —H, -Me, -tBu, —OMe, -iPr.
  • R 2 , R 4 are selected from: -Me, -tBu, —OMe, -iPr.
  • R 2 , R 4 are selected from: -Me, -tBu, —OMe.
  • R 2 is selected from: -Me, -tBu, —OMe.
  • R 2 is selected from: -tBu, —OMe.
  • R 2 is selected from: -Me, —OMe.
  • R 2 is —OMe
  • R 3 is —H.
  • R 4 is selected from: -Me, -tBu, —OMe.
  • R 4 is selected from: -tBu, —OMe.
  • R 4 is selected from: -Me, -tBu.
  • R 4 is -tBu.
  • the compound has the formula (1):
  • R 2 , R 3 , R 4 are selected from: —H, —(C 1 -C 12 )-alkyl, —O—(C 1 -C 12 )-alkyl, wherein the alkyl groups mentioned may be substituted as follows: substituted —(C 1 -C 12 )-alkyl groups and substituted —(C 1 -C 12 )-alkoxy groups, depending on their chain length, may have one or more substituents; the substituents are mutually independently selected from —(C 3 -C 12 )-cycloalkyl, —(C 3 -C 12 )-heterocycloalkyl, —(C 6 -C 20 )-aryl, fluorine, chlorine, cyano, formyl, acyl or alkoxycarbonyl; and M is selected from: Rh, Ru, Co, Ir.
  • M Rh.
  • R 2 , R 3 , R 4 are selected from: —H, -Me, -tBu, —OMe, -iPr.
  • R 2 , R 4 are selected from: -Me, -tBu, —OMe, -iPr.
  • R 2 , R 4 are selected from: -Me, -tBu, —OMe.
  • R 2 is selected from: -Me, -tBu, —OMe.
  • R 2 is selected from: -tBu, —OMe.
  • R 2 is selected from: -Me, —OMe.
  • R 2 is —OMe
  • R 3 is —H.
  • R 4 is selected from: -Me, -tBu, —OMe.
  • R 4 is selected from: -tBu, —OMe.
  • R 4 is selected from: -Me, -tBu.
  • R 4 is -tBu.
  • R 2 , R 3 , R 4 are selected from: —H, —(C 1 -C 12 )-alkyl, —O—(C 1 -C 12 )-alkyl, wherein the alkyl groups mentioned may be substituted as follows: substituted —(C 1 -C 12 )-alkyl groups and substituted —(C 1 -C 12 )-alkoxy groups, depending on their chain length, may have one or more substituents; the substituents are mutually independently selected from —(C 3 -C 12 )-cycloalkyl, —(C 3 -C 12 )-heterocycloalkyl, —(C 6 -C 20 )-aryl, fluorine, chlorine, cyano, formyl, acyl or alkoxycarbonyl; and M is selected from: Rh, Ru, Co, Ir.
  • M Rh.
  • R 2 , R 3 , R 4 are selected from: —H, -Me, -tBu, —OMe, -iPr.
  • R 2 , R 4 are selected from: -Me, -tBu, —OMe, -iPr.
  • R 2 , R 4 are selected from: -Me, -tBu, —OMe.
  • R 2 is selected from: -Me, -tBu, —OMe.
  • R 2 is selected from: -tBu, —OMe.
  • R 2 is selected from: -Me, —OMe.
  • R 2 is —OMe
  • R 3 is —H.
  • R 4 is selected from: -Me, -tBu, —OMe.
  • R 4 is selected from: -tBu, —OMe.
  • R 4 is selected from: -Me, -tBu.
  • R 4 is -tBu.
  • hydroformylation process is also claimed in which the compound (I) or the complex (II) or (III) is used.
  • Process steps a) to c) can be carried out here in any desired sequence.
  • the compound may be used as a ligand in a ligand-metal complex.
  • each ligand is not necessarily present bound in the form of a ligand-metal complex but is present as free ligand in the reaction mixture.
  • the reaction is conducted under customary conditions.
  • the metal is Rh.
  • the reactants for the hydroformylation in the process of the invention are olefins or mixtures of olefins, especially monoolefins having 2 to 24, preferably 3 to 16 and particularly preferably 3 to 12 carbon atoms, having terminal or internal C—C double bonds, for example 1-propene, 1-butene, 2-butene, 1- or 2-pentene, 2-methyl-1-butene, 2-methyl-2-butene, 3-methyl-1-butene, 1-, 2- or 3-hexene, the C 6 olefin mixture obtained in the dimerization of propene (dipropene), heptenes, 2- or 3-methyl-1-hexenes, octenes, 2-methylheptenes, 3-methylheptenes, 5-methyl-2-heptene, 6-methyl-2-heptene, 2-ethyl-1-hexene, the C 8 olefin mixture obtained in the dimerization of butenes (di-n-butene
  • the process according to the invention using the ligands according to the invention can be used to hydroformylate ⁇ -olefins, terminally branched, internal and internally branched olefins.
  • the high yield of terminal hydroformylated olefins is notable in this case, even when only a low proportion of olefins having terminal double bonds was present in the reactant.
  • the recording of nuclear resonance spectra was effected on Bruker Avance 300 or Bruker Avance 400, gas chromatography analysis on Agilent GC 7890A, elemental analysis on Leco TruSpec CHNS and Varian ICP-OES 715, and ESI-TOF mass spectrometry on Thermo Electron Finnigan MAT 95-XP and Agilent 6890 N/5973 instruments.
  • the hydrochloride formed was filtered off and rinsed with 60 ml of dry toluene and the resulting mother liquor was concentrated to dryness under reduced pressure.
  • the crude solution was distilled.
  • a pear-shaped flask was filled with the crude solution, on which flask a short distillation apparatus without cooling jacket was placed.
  • the thermometer was placed at the upper opening, and at the other end a spider with four further pear-shaped flasks was attached. Subsequently, this apparatus was attached to a cold trap and from there to the high vacuum pump.
  • the pear-shaped flask with the crude ligand to be distilled was heated by means of an oil bath. Firstly, the forerun was removed at a top temperature of 25-30° C.
  • the spider was then further rotated and the main run was removed at a top temperature of 140° C. When no more drops appeared in the main run, the distillation was stopped, the pump was shut down and the main run in the relevant pear-shaped flask was removed, sealed and analysed.
  • the suspension was then filtered off, washed thoroughly with 30 ml of acetonitrile and dried.
  • this ligand was purified.
  • the chlorine contents reported are meant as total chlorine contents.
  • the total chlorine content is determined according to Wickbold: sample preparation according to DIN 51408 and analysis by ion chromatography according to DIN EN ISO 10304.
  • Rh(acac)(CO) 2 was initially charged in toluene.
  • the ligand was used in a molar excess of 4:1 relative to rhodium.
  • Tinuvin 770DF was used as stabilizer in a molar ratio to the ligand of ca. 1:1.
  • TIPB tetraisopropylbenzene
  • the n-pentanal regioselectivity signifies that this amount of linear product was formed.
  • the remaining percentages then correspond to the branched isomer. Rate of selectivity was estimated by gas chromatography.
  • Ligands (5) (entry 1) and (6) (entry 4) have a very good n-pentanal regioselectivity and achieve good or at least moderate yields of aldehydes.
  • Isomer (4) (entry 2) has a lower n-pentanal selectivity of only 90% and distinctly lower activities, i.e. yields. The best selectivity of 98% is achieved with the ligand (1) according to the invention. Beyond that, ligand (1) has an excellent yield of 95%.

Abstract

The invention relates to bisphosphites having 2,4-dimethylphenyl units and a method for the preparation thereof. Furthermore, the invention relates to the use of the compounds as ligands in a ligand-metal complex. The compound, and also the complex, may be used as a catalytically active composition in hydroformylation reactions.

Description

  • The invention relates to bisphosphites having 2,4-dimethylphenyl units and a method for the preparation thereof. Furthermore, the invention relates to the use of the compounds as ligands in a ligand-metal complex. The compound, and also the complex, may be used as a catalytically active composition in hydroformylation reactions.
  • Phosphorus-containing compounds, as ligands, play a crucial role in a multitude of reactions. Said compounds include phosphite ligands, i.e., compounds comprising P—O bonds, used in hydrogenation, hydrocyanation and especially hydroformylation.
  • The reactions between olefin compounds, carbon monoxide and hydrogen in the presence of a catalyst to give the aldehydes comprising one additional carbon atom are known as hydroformylation or oxo synthesis. In these reactions, compounds of the transition metals of group VIII of the Periodic Table of the Elements are frequently employed as catalysts. Known ligands include, for example, compounds of the phosphine, phosphite and phosphonite classes each comprising trivalent phosphorus PIII. A good overview of the status of hydroformylation of olefins is found in R. Franke, D. Selent, A. Börner, “Applied Hydroformylation”, Chem. Rev., 2012, DOI:10.1021/cr3001803.
  • The literature discloses the synthesis of symmetric bisphosphites, as disclosed in U.S. Pat. No. 4,769,498 for example, and the use thereof in catalytically active transition metal-containing compositions for the hydroformylation of unsaturated compounds.
  • In U.S. Pat. No. 4,769,498, and also in U.S. Pat. No. 5,723,641, preferably symmetric bisphosphites are prepared and used as ligands for hydroformylation. The symmetric bisphosphite ligands used in the hydroformylation are prepared at low temperatures. Adherence to these low temperatures is absolutely necessary since according to these US documents higher temperatures would lead to rearrangements and ultimately to asymmetric bisphosphites.
  • One of the best catalysts at present for the hydroformylation of olefins is to use an asymmetrical bisphoshite as ligand, 4,8-di-tert-butyl-2,10-dimethoxy-6-((3,3′,5,5′-tetramethyl-2′-((2,4,8,10-tetramethyldibenzo[d,f][1,3,2]dioxa phosphepin-6-yl)oxy)-[1,1′-biphenyl]-2-yl)oxy)dibenzo[d,f][1,3,2] dioxaphosphepine. This is characterized by a very good yield in combination with very good regioselectivity.
  • However, this ligand is very expensive to prepare due to its many synthetic stages. Since the price of ligands has an essential influence of the overall cost-effectiveness of a method, it is desirable to find alternative ligands with comparably good properties (yield and regioselectivity) but which are more cost-effective in terms of their preparation.
  • The technical object of the invention is the provision of a novel ligand which does not have the above-detailed disadvantages from the prior art in the hydroformylation of unsaturated compounds, but instead has the following properties:
  • 1) a good activity/yield,
    2) a high n-regioselectivity with respect to hydroformylation,
    3) comparatively favourable preparation.
  • The object is achieved by a compound according to claim 1.
  • Compound of the formula (I):
  • Figure US20170129838A1-20170511-C00001
  • where
    R2, R3, R4 are selected from: —H, —(C1-C12)-alkyl, —O—(C1-C12)-alkyl,
    wherein the alkyl groups mentioned may be substituted as follows:
    substituted —(C1-C12)-alkyl groups and substituted —(C1-C12)-alkoxy groups, depending on their chain length, may have one or more substituents; the substituents are mutually independently selected from —(C3-C12)-cycloalkyl, —(C3-C12)-heterocycloalkyl, —(C6-C20)-aryl, fluorine, chlorine, cyano, formyl, acyl or alkoxycarbonyl.
  • In the context of the invention, the expression “—(C1-C12)-alkyl” encompasses straight-chain and branched alkyl groups. Preferably, these groups are unsubstituted straight-chain or branched —(C1-C8)-alkyl groups and most preferably —(C1-C6)-alkyl groups. Examples of —(C1-C12)-alkyl groups are especially methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, 2-pentyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, 2-hexyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 2,2-dimethylbutyl, 1,3-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethylbutyl, 1-ethyl-2-methylpropyl, n-heptyl, 2-heptyl, 3-heptyl, 2-ethylpentyl, 1-propylbutyl, n-octyl, 2-ethylhexyl, 2-propylheptyl, nonyl, decyl.
  • The elucidations relating to the expression “—(C1-C12)-alkyl” also apply to the alkyl groups in —O—(C1-C12)-alkyl, i.e. in —(C1-C12)-alkoxy. Preferably, these groups are unsubstituted straight-chain or branched —(C1-C6)-alkoxy groups.
  • Substituted —(C1-C12)-alkyl groups and substituted —(C1-C12)-alkoxy groups, depending on their chain length, may have one or more substituents; the substituents are mutually independently selected from —(C3-C12)-cycloalkyl, —(C3-C12)-heterocycloalkyl, —(C6-C20)-aryl, fluorine, chlorine, cyano, formyl, acyl or alkoxycarbonyl.
  • In one embodiment, R2, R3, R4 are selected from: —H, -Me, -tBu, —OMe, -iPr.
  • In one embodiment, R2, R4 are selected from: -Me, -tBu, —OMe, -iPr.
  • In one embodiment, R2, R4 are selected from: -Me, -tBu, —OMe.
  • In one embodiment, R2 is selected from: -Me, -tBu, —OMe.
  • In one embodiment, R2 is selected from: -tBu, —OMe.
  • In one embodiment, R2 is selected from: -Me, —OMe.
  • In one embodiment, R2 is —OMe.
  • In one embodiment, R3 is —H.
  • In one embodiment, R4 is selected from: -Me, -tBu, —OMe.
  • In one embodiment, R4 is selected from: -tBu, —OMe.
  • In one embodiment, R4 is selected from: -Me, -tBu.
  • In one embodiment, R4 is -tBu.
  • In one embodiment, the compound has the formula (1):
  • Figure US20170129838A1-20170511-C00002
  • As well as the compounds, also claimed are complexes comprising the compound.
  • Complex according to the formula (II):
  • Figure US20170129838A1-20170511-C00003
  • where
    R2, R3, R4 are selected from: —H, —(C1-C12)-alkyl, —O—(C1-C12)-alkyl,
    wherein the alkyl groups mentioned may be substituted as follows:
    substituted —(C1-C12)-alkyl groups and substituted —(C1-C12)-alkoxy groups, depending on their chain length, may have one or more substituents; the substituents are mutually independently selected from —(C3-C12)-cycloalkyl, —(C3-C12)-heterocycloalkyl, —(C6-C20)-aryl, fluorine, chlorine, cyano, formyl, acyl or alkoxycarbonyl;
    and M is selected from: Rh, Ru, Co, Ir.
  • In a preferred embodiment, M=Rh.
  • In one embodiment, R2, R3, R4 are selected from: —H, -Me, -tBu, —OMe, -iPr.
  • In one embodiment, R2, R4 are selected from: -Me, -tBu, —OMe, -iPr.
  • In one embodiment, R2, R4 are selected from: -Me, -tBu, —OMe.
  • In one embodiment, R2 is selected from: -Me, -tBu, —OMe.
  • In one embodiment, R2 is selected from: -tBu, —OMe.
  • In one embodiment, R2 is selected from: -Me, —OMe.
  • In one embodiment, R2 is —OMe.
  • In one embodiment, R3 is —H.
  • In one embodiment, R4 is selected from: -Me, -tBu, —OMe.
  • In one embodiment, R4 is selected from: -tBu, —OMe.
  • In one embodiment, R4 is selected from: -Me, -tBu.
  • In one embodiment, R4 is -tBu.
  • Complex according to the formula (III):
  • Figure US20170129838A1-20170511-C00004
  • where
    R2, R3, R4 are selected from: —H, —(C1-C12)-alkyl, —O—(C1-C12)-alkyl,
    wherein the alkyl groups mentioned may be substituted as follows:
    substituted —(C1-C12)-alkyl groups and substituted —(C1-C12)-alkoxy groups, depending on their chain length, may have one or more substituents; the substituents are mutually independently selected from —(C3-C12)-cycloalkyl, —(C3-C12)-heterocycloalkyl, —(C6-C20)-aryl, fluorine, chlorine, cyano, formyl, acyl or alkoxycarbonyl;
    and M is selected from: Rh, Ru, Co, Ir.
  • In a preferred embodiment, M=Rh.
  • In one embodiment, R2, R3, R4 are selected from: —H, -Me, -tBu, —OMe, -iPr.
  • In one embodiment, R2, R4 are selected from: -Me, -tBu, —OMe, -iPr.
  • In one embodiment, R2, R4 are selected from: -Me, -tBu, —OMe.
  • In one embodiment, R2 is selected from: -Me, -tBu, —OMe.
  • In one embodiment, R2 is selected from: -tBu, —OMe.
  • In one embodiment, R2 is selected from: -Me, —OMe.
  • In one embodiment, R2 is —OMe.
  • In one embodiment, R3 is —H.
  • In one embodiment, R4 is selected from: -Me, -tBu, —OMe.
  • In one embodiment, R4 is selected from: -tBu, —OMe.
  • In one embodiment, R4 is selected from: -Me, -tBu.
  • In one embodiment, R4 is -tBu.
  • In addition to the compound and the complexes comprising the compound, the use of compound (I) and the complexes (II) or (III) for catalysis of a hydroformylation reaction is also claimed.
  • Use of the compound (I) in a ligand-metal complex for catalysis of a hydroformylation reaction.
  • Use of the complex (II) for catalysis of a hydroformylation reaction.
  • Use of the complex (III) for catalysis of a hydroformylation reaction.
  • Furthermore, the hydroformylation process is also claimed in which the compound (I) or the complex (II) or (III) is used.
  • Process comprising the following process steps:
  • a) initially charging an olefin,
      • b) adding an above-described complex,
        or an above-described compound and a substance including a metal selected from: Rh, Ru, Co, Ir,
        c) feeding in H2 and CO,
        d) heating the reaction mixture, wherein the olefin is converted to an aldehyde.
  • Process steps a) to c) can be carried out here in any desired sequence.
  • The compound may be used as a ligand in a ligand-metal complex.
  • An excess of ligands can also be used in this case and each ligand is not necessarily present bound in the form of a ligand-metal complex but is present as free ligand in the reaction mixture.
  • The reaction is conducted under customary conditions.
  • Preference is given to a temperature of 80° C. to 160° C. and a pressure of 1 to 300 bar. Particular preference is given to a temperature of 100° C. to 160° C. and a pressure of 15 to 250 bar.
  • In a preferred embodiment, the metal is Rh.
  • The reactants for the hydroformylation in the process of the invention are olefins or mixtures of olefins, especially monoolefins having 2 to 24, preferably 3 to 16 and particularly preferably 3 to 12 carbon atoms, having terminal or internal C—C double bonds, for example 1-propene, 1-butene, 2-butene, 1- or 2-pentene, 2-methyl-1-butene, 2-methyl-2-butene, 3-methyl-1-butene, 1-, 2- or 3-hexene, the C6 olefin mixture obtained in the dimerization of propene (dipropene), heptenes, 2- or 3-methyl-1-hexenes, octenes, 2-methylheptenes, 3-methylheptenes, 5-methyl-2-heptene, 6-methyl-2-heptene, 2-ethyl-1-hexene, the C8 olefin mixture obtained in the dimerization of butenes (di-n-butene, diisobutene), nonenes, 2- or 3-methyloctenes, the C9 olefin mixture obtained in the trimerization of propene (tripropene), decenes, 2-ethyl-1-octene, dodecenes, the C12 olefin mixture obtained in the tetramerization of propene or the trimerization of butenes (tetrapropene or tributene), tetradecenes, hexadecenes, the C16 olefin mixture obtained in the tetramerization of butenes (tetrabutene), and olefin mixtures prepared by cooligomerization of olefins having different numbers of carbon atoms (preferably 2 to 4).
  • The process according to the invention using the ligands according to the invention can be used to hydroformylate α-olefins, terminally branched, internal and internally branched olefins. The high yield of terminal hydroformylated olefins is notable in this case, even when only a low proportion of olefins having terminal double bonds was present in the reactant.
  • The invention is to be illustrated in greater detail hereinafter by working examples.
    • GENERAL PROCEDURE SPECIFICATIONS
  • All the preparations which follow were carried out under protective gas using standard Schlenk techniques. The solvents were dried over suitable desiccants before use (Purification of Laboratory Chemicals, W. L. F. Armarego (Author), Christina Chai (Author), Butterworth Heinemann (Elsevier), 6th edition, Oxford 2009).
  • Phosphorus trichloride (Aldrich) was distilled under argon before use. All preparative operations were effected in baked-out vessels. The products were characterized by means of NMR spectroscopy. Chemical shifts (δ) are reported in ppm. The 31P NMR signals were referenced as follows: SR31P=SR1H*(BF31P/BF1H)=SR1H*0.4048 (Robin K. Harris, Edwin D. Becker, Sonia M. Cabral de Menezes, Robin Goodfellow, and Pierre Granger, Pure Appl. Chem., 2001, 73, 1795-1818; Robin K. Harris, Edwin D. Becker, Sonia M. Cabral de Menezes, Pierre Granger, Roy E. Hoffman and Kurt W. Zilm, Pure Appl. Chem., 2008, 80, 59-84).
  • The recording of nuclear resonance spectra was effected on Bruker Avance 300 or Bruker Avance 400, gas chromatography analysis on Agilent GC 7890A, elemental analysis on Leco TruSpec CHNS and Varian ICP-OES 715, and ESI-TOF mass spectrometry on Thermo Electron Finnigan MAT 95-XP and Agilent 6890 N/5973 instruments.
    • General Reaction Equation (Comparative Ligands)
  • Figure US20170129838A1-20170511-C00005
    • General Reaction Equation (Inventive Ligand)
  • Figure US20170129838A1-20170511-C00006
  • As is clear by means of comparing the two reaction schemes, fewer synthetic stages are required for compound (1) than for compound (4) or (5). In the preparation of compound (1), the 2,4-dimethylphenol does not have to be first coupled to a biphenol, but can be reacted directly with PCl3 to give the corresponding chlorophosphite.
    • Preparation of bis(2,4-dimethylphenyl)chlorophosphite
  • Figure US20170129838A1-20170511-C00007
  • 50 g of PCl3 (0.363 mol) and 86 g of pyridine (1.076 mol) in 380 ml of dry toluene were initially charged in a secured 1200 ml glass reactor provided with a dropping funnel. The milky yellow PCl3/pyridine solution was cooled down to −7° C. with stirring. 86 ml of 2,4-dimethylphenol (0.720 mol) were then added to the dropping funnel and dissolved in 380 ml of dry toluene. To carry out the reaction, the phenol/toluene solution was added dropwise slowly and steadily to the PCl3/pyridine solution. The reaction mixture was brought to room temperature overnight with stirring.
  • For workup, the hydrochloride formed was filtered off and rinsed with 60 ml of dry toluene and the resulting mother liquor was concentrated to dryness under reduced pressure.
  • For further work-up, the crude solution was distilled. For this purpose, a pear-shaped flask was filled with the crude solution, on which flask a short distillation apparatus without cooling jacket was placed. The thermometer was placed at the upper opening, and at the other end a spider with four further pear-shaped flasks was attached. Subsequently, this apparatus was attached to a cold trap and from there to the high vacuum pump. The pear-shaped flask with the crude ligand to be distilled was heated by means of an oil bath. Firstly, the forerun was removed at a top temperature of 25-30° C. The spider was then further rotated and the main run was removed at a top temperature of 140° C. When no more drops appeared in the main run, the distillation was stopped, the pump was shut down and the main run in the relevant pear-shaped flask was removed, sealed and analysed.
    • Result:
  • Total mass: 56.7 g (46% yield)
    • Preparation of 3,3′-di-tert-butyl-5,5′-dimethoxy-[1,1′-biphenyl]-2,2′-diyltetrakis(2,4-dimethylphenyl)bis(phosphite)
  • Figure US20170129838A1-20170511-C00008
  • In a 1000 mL Schlenk flask, 260 ml of dry acetonitrile were added to 51.86 g (0.153 mol) of bis(2,4-dimethylphenyl)chlorophosphite at room temperature with stirring and the chlorophosphite was dissolved.
  • In a second 250 ml Schlenk flask, 12.4 ml (0.153 mol) of pyridine and 155 ml of dry acetonitrile were added to 20.1 g (0.056 mol) of 3,3′-di-tert-butyl-5,5′-dimethoxy-[1,1′-biphenyl]-2,2′-diol. The chlorophosphite solution in the Schlenk flask was then cooled to 0° C. The biphenol/pyridine solution was then slowly added dropwise with vigorous stirring. The reaction mixture was maintained at this temperature for ca. 3 h and then very slowly brought to room temperature overnight.
  • The suspension was then filtered off, washed thoroughly with 30 ml of acetonitrile and dried.
    • Result:
  • Mass: 44.01 g (yield: 85%)
    • Reduction of Chlorine Level
  • In order to decrease the chlorine content in this crude ligand, this ligand was purified.
  • The chlorine contents reported are meant as total chlorine contents.
  • The total chlorine content is determined according to Wickbold: sample preparation according to DIN 51408 and analysis by ion chromatography according to DIN EN ISO 10304.
  • 5.15 g of 3,3′-di-tert-butyl-5,5′-dimethoxy-[1,1-biphenyl]-2,2′-diyltetrakis(2,4-dimethylphenyl)bis(phosphite) in a first 250 ml Schlenk flask with 15 ml of degassed toluene and 5 ml of pyridine at 100° C. were stirred until the 3,3′-di-tert-butyl-5,5′-dimethoxy-[1,1′-biphenyl]-2,2′-diyltetrakis(2,4-dimethylphenyl)bis(phosphate) had dissolved. After all had dissolved, the temperature was maintained for a further 15 min and then cooled to 90° C.
  • Meanwhile, 100 ml of heptane and 5 ml of pyridine were placed in a second 250 ml Schlenk flask and this solution was cooled down to 0° C. Subsequently, the solution from the first Schlenk flask was added via a frit to the second Schlenk flask with the cold heptane/pyridine solution and stirred at 0° C. for 3 h. No precipitate was observed. By means of a vacuum pump, the solvent mixture was drawn off until the solid had precipitated and was dried. After that, 50 ml of acetonitrile was given onto the dried solid. This suspension has been stirred for two days at room temperature, fritted and dried by means of a vacuum pump.
    • Result:
  • Mass: 3.7 g
  • Chlorine determination: 20/20 ppm
    • Procedure for the Catalysis Experiments Experimental Description—General
  • In a 100 ml autoclave from Parr Instruments, cis-2-butene was hydroformylated with the aid of synthesis gas pressure (CO/H2=1:1 (% by vol.)). As the precursor, Rh(acac)(CO)2 was initially charged in toluene. The ligand was used in a molar excess of 4:1 relative to rhodium. Tinuvin 770DF was used as stabilizer in a molar ratio to the ligand of ca. 1:1. In addition, as GC standard, ca. 0.5 g of tetraisopropylbenzene (TIPB) was added. About 6 g of reactant were metered in after the reaction temperature envisaged had been attained.
  • During the reaction, the pressure was kept constant via synthesis gas regulation with a mass flow meter. The stirrer speed was 1200 min−1. Samples were taken from the reaction mixture after 12 hours. The results of the experiments are summarized in Table 1.
  • Figure US20170129838A1-20170511-C00009
    • Experimental Description—Specific
  • In a 100 ml autoclave from Parr Instruments, 5.6 g of cis-2-butene were hydroformylated at 120° C. and 20 bar synthesis gas pressure. As the precursor, 0.0056 g of Rh(acac)(CO)2 was initially charged in 48.8 g of toluene. As the ligand, 0.0779 g of ligand was used in the catalyst mixture solution. 0.0416 g of Tinuvin 770DF was added as the organic amine, and a GC standard. The reactant was metered in after attainment of the reaction temperature envisaged.
  • During the reaction, the pressure was kept constant via synthesis gas regulation with a mass flow meter. Samples were taken from the reaction mixture after 12 hours.
  • Furthermore, compound (5), its symmetrical isomer compound (4) and compound (6) were tested under corresponding conditions. These compounds were prepared according to WO 2014/056733 A1, EP 2 907 819 A1 and WO 2007/109005A2 respectively.
  • In Table 1 the hydroformylation results of cis-2-butene at 20 bar synthesis gas pressure are shown.
  • Figure US20170129838A1-20170511-C00010
  • TABLE 1
    Aldehyde
    yield in Regioselectivity
    Entry Ligand [%] n-pentanal in %
    1 5 95 94
    2 4 66 90
    3  1* 95 98
    4 6 79 98
    *inventive compound
    • Definition of the Selectivity:
  • in hydroformylation, there is the n/iso selectivity (n/iso=the ratio of linear aldehyde (=n) to branched (=iso) aldehyde). In this case, the n-pentanal regioselectivity signifies that this amount of linear product was formed. The remaining percentages then correspond to the branched isomer. Rate of selectivity was estimated by gas chromatography.
  • Ligands (5) (entry 1) and (6) (entry 4) have a very good n-pentanal regioselectivity and achieve good or at least moderate yields of aldehydes. Isomer (4) (entry 2) has a lower n-pentanal selectivity of only 90% and distinctly lower activities, i.e. yields. The best selectivity of 98% is achieved with the ligand (1) according to the invention. Beyond that, ligand (1) has an excellent yield of 95%.
  • The experiments carried out demonstrate that the objects presented are achieved by the compound (1) according to the invention.

Claims (13)

1. Compound of the formula (I):
Figure US20170129838A1-20170511-C00011
where
R2, R3, R4 are selected from: —H, —(C1-C12)-alkyl, —O—(C1-C12)-alkyl,
wherein the alkyl groups mentioned may be substituted as follows:
substituted —(C1-C12)-alkyl groups and substituted —(C1-C12)-alkoxy groups, depending on their chain length, may have one or more substituents; the substituents are mutually independently selected from —(C3-C12)-cycloalkyl, —(C3-C12)-heterocycloalkyl, —(C6-C20)-aryl, fluorine, chlorine, cyano, formyl, acyl or alkoxycarbonyl.
2. Compound according to claim 1,
where R2 is selected from: -Me, -tBu, —OMe.
3. Compound according to claim 1,
where R2 is —OMe.
4. Compound according to claim 1,
where R4 is selected from: -Me, -tBu, —OMe.
5. Compound according to claim 1,
where R4 is -tBu.
6. Compound according to claim 1,
according to the formula (1):
Figure US20170129838A1-20170511-C00012
7. Complex according to the formula (II):
Figure US20170129838A1-20170511-C00013
where
R2, R3, R4 are selected from: —H, —(C1-C12)-alkyl, —O—(C1-C12)-alkyl,
wherein the alkyl groups mentioned may be substituted as follows:
substituted —(C1-C12)-alkyl groups and substituted —(C1-C12)-alkoxy groups, depending on their chain length, may have one or more substituents; the substituents are mutually independently selected from —(C3-C12)-cycloalkyl, —(C3-C12)-heterocycloalkyl, —(C6-C20)-aryl, fluorine, chlorine, cyano, formyl, acyl or alkoxycarbonyl;
and M is selected from: Rh, Ru, Co, Ir.
8. Complex according to the formula (III):
Figure US20170129838A1-20170511-C00014
where
R2, R3, R4 are selected from: —H, —(C1-C12)-alkyl, —O—(C1-C12)-alkyl,
wherein the alkyl groups mentioned may be substituted as follows:
substituted —(C1-C12)-alkyl groups and substituted —(C1-C12)-alkoxy groups, depending on their chain length, may have one or more substituents; the substituents are mutually independently selected from —(C3-C12)-cycloalkyl, —(C3-C12)-heterocycloalkyl, —(C6-C20)-aryl, fluorine, chlorine, cyano, formyl, acyl or alkoxycarbonyl;
and M is selected from: Rh, Ru, Co, Ir.
9. Complex according to claim 7,
where M=Rh.
10. Use of a compound according to claim 1,
in a ligand-metal complex for catalysis of a hydroformylation reaction.
11. Process comprising the following process steps:
a) initially charging an olefin,
b) adding a complex according to claim 7,
c) feeding in H2 and CO,
d) heating the reaction mixture, wherein the olefin is converted to an aldehyde.
12. Process comprising the following process steps:
a) initially charging an olefin,
b) adding a compound according to claim 1 and a substance including a metal selected from: Rh, Ru, Co, Ir,
c) feeding in H2 and CO,
d) heating the reaction mixture, wherein the olefin is converted to an aldehyde.
13. Complex according to claim 8,
where M=Rh.
US15/345,962 2015-11-09 2016-11-08 Bisphosphites having 2,4-dimethylphenyl units and use thereof as ligands in hydroformylation Abandoned US20170129838A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15193607 2015-11-09
EP15193607 2015-11-09

Publications (1)

Publication Number Publication Date
US20170129838A1 true US20170129838A1 (en) 2017-05-11

Family

ID=54539874

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/773,613 Active US10227278B2 (en) 2015-11-09 2016-08-02 Economical production of 2-propylheptanol
US15/345,962 Abandoned US20170129838A1 (en) 2015-11-09 2016-11-08 Bisphosphites having 2,4-dimethylphenyl units and use thereof as ligands in hydroformylation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US15/773,613 Active US10227278B2 (en) 2015-11-09 2016-08-02 Economical production of 2-propylheptanol

Country Status (12)

Country Link
US (2) US10227278B2 (en)
EP (1) EP3374366B1 (en)
JP (1) JP2017125005A (en)
KR (2) KR102602992B1 (en)
CN (2) CN108350010B (en)
CA (1) CA3001157C (en)
ES (1) ES2770300T3 (en)
MY (1) MY182378A (en)
PL (1) PL3374366T3 (en)
SG (2) SG11201803440QA (en)
WO (1) WO2017080690A1 (en)
ZA (1) ZA201803659B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190169105A1 (en) * 2017-12-01 2019-06-06 Evonik Degussa Gmbh Method for obtaining alcohols from aldehydes III
US20190169104A1 (en) * 2017-12-01 2019-06-06 Evonik Degussa Gmbh Method for obtaining alcohols from aldehydes II
US20190169106A1 (en) * 2017-12-01 2019-06-06 Evonik Degussa Gmbh Method for obtaining alcohols from aldehydes
US10526356B2 (en) 2016-11-08 2020-01-07 Evonik Degussa Gmbh Bisphosphites having 2,4-tert-butylphenyl units and use thereof as ligands in hydroformylation
US10793497B2 (en) 2017-08-24 2020-10-06 Mitsubishi Chemical Corporation Dihydroxybiphenyl compound, bisphosphite compound, catalyst, production method of aldehydes, and production method of alcohol
US11027266B2 (en) 2016-11-08 2021-06-08 Evonik Operations Gmbh Phosphorous acid P,P′-[5,5′,6,6′-tetramethyl-3,3′-bis(l- methylethyl)[1,1′-biphenyl]-2,2′-diyl] P,P,P′,P'-tetrakis(2,4-dimethylphenyl) ester in hydroformylation
US11519020B2 (en) 2018-05-25 2022-12-06 Regeneron Pharmaceuticals, Inc. Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
US11769597B2 (en) 2015-12-03 2023-09-26 Regeneron Pharmaceuticals, Inc. Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3549996A1 (en) 2018-04-03 2019-10-09 Evonik Degussa GmbH Olefins based on fischer-tropsch synthesis
CN116390904A (en) 2020-10-23 2023-07-04 埃克森美孚化学专利公司 Method for producing higher alcohols from waste plastic pyrolysis oil and higher alcohols obtained therefrom
EP4074720B1 (en) * 2021-04-16 2023-07-19 Evonik Operations GmbH Mixture of bisphosphites with an open and a closed volatile building block and its use as catalyst mixture in hydroformylation
EP4273119A1 (en) 2022-05-03 2023-11-08 Evonik Operations GmbH Method for the preparation of c5 aldehydes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3812046B2 (en) * 1996-04-30 2006-08-23 三菱化学株式会社 Bisphosphite compound and hydroformylation method using the same
DE10333519A1 (en) * 2003-07-23 2005-02-17 Basf Ag Two-stage hydroformylation process
GB0322247D0 (en) * 2003-09-23 2003-10-22 Exxonmobil Chem Patents Inc Improvement in or relating to an isobutylene containing stream
CN101332437A (en) * 2008-05-29 2008-12-31 上海焦化有限公司 Butene hydroformylation catalyst composition and uses thereof
DE102008002187A1 (en) * 2008-06-03 2009-12-10 Evonik Oxeno Gmbh Process for the preparation of C5-aldehyde mixtures with high n-pentanal content
KR101293818B1 (en) * 2010-03-09 2013-08-07 주식회사 엘지화학 METHOD FOR PREPARING α, β-UNSATURATED ALDEHYDE

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11769597B2 (en) 2015-12-03 2023-09-26 Regeneron Pharmaceuticals, Inc. Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
US10526356B2 (en) 2016-11-08 2020-01-07 Evonik Degussa Gmbh Bisphosphites having 2,4-tert-butylphenyl units and use thereof as ligands in hydroformylation
US11027266B2 (en) 2016-11-08 2021-06-08 Evonik Operations Gmbh Phosphorous acid P,P′-[5,5′,6,6′-tetramethyl-3,3′-bis(l- methylethyl)[1,1′-biphenyl]-2,2′-diyl] P,P,P′,P'-tetrakis(2,4-dimethylphenyl) ester in hydroformylation
US10793497B2 (en) 2017-08-24 2020-10-06 Mitsubishi Chemical Corporation Dihydroxybiphenyl compound, bisphosphite compound, catalyst, production method of aldehydes, and production method of alcohol
US20190169105A1 (en) * 2017-12-01 2019-06-06 Evonik Degussa Gmbh Method for obtaining alcohols from aldehydes III
US20190169104A1 (en) * 2017-12-01 2019-06-06 Evonik Degussa Gmbh Method for obtaining alcohols from aldehydes II
US20190169106A1 (en) * 2017-12-01 2019-06-06 Evonik Degussa Gmbh Method for obtaining alcohols from aldehydes
US10501392B2 (en) * 2017-12-01 2019-12-10 Evonik Degussa Gmbh Method for obtaining alcohols from aldehydes II
US10562833B2 (en) * 2017-12-01 2020-02-18 Evonik Degussa Gmbh Method for obtaining alcohols from aldehydes III
US10577297B2 (en) * 2017-12-01 2020-03-03 Evonik Operations Gmbh Method for obtaining alcohols from aldehydes
US11519020B2 (en) 2018-05-25 2022-12-06 Regeneron Pharmaceuticals, Inc. Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF

Also Published As

Publication number Publication date
SG11201803440QA (en) 2018-05-30
US10227278B2 (en) 2019-03-12
EP3374366A1 (en) 2018-09-19
KR102602992B1 (en) 2023-11-17
JP2017125005A (en) 2017-07-20
PL3374366T3 (en) 2020-05-18
MY182378A (en) 2021-01-21
ES2770300T3 (en) 2020-07-01
US20180319727A1 (en) 2018-11-08
CA3001157A1 (en) 2017-05-18
WO2017080690A1 (en) 2017-05-18
ZA201803659B (en) 2019-07-31
CN108350010A (en) 2018-07-31
KR20170054305A (en) 2017-05-17
SG10201609317SA (en) 2017-06-29
EP3374366B1 (en) 2019-12-18
CN106674271A (en) 2017-05-17
CN108350010B (en) 2020-09-04
CA3001157C (en) 2023-06-20
KR20180081510A (en) 2018-07-16

Similar Documents

Publication Publication Date Title
US20170129838A1 (en) Bisphosphites having 2,4-dimethylphenyl units and use thereof as ligands in hydroformylation
US9221850B2 (en) Monophosphite ligands having a tert-butyloxycarbonyl group
US9409844B2 (en) Mixture of different asymmetrical bisophosphites and use thereof as a catalyst mixture in hydroformylation
US9737884B2 (en) Process for catalytic preparation of aldehydes from olefins using monophosphite mixtures
US11739108B2 (en) Diphosphites having an open, 2,4-methylated outer unit
EP2445920B1 (en) Phosphite containing catalysts for hydroformylation processes
US10526356B2 (en) Bisphosphites having 2,4-tert-butylphenyl units and use thereof as ligands in hydroformylation
US20160159837A1 (en) Monophosphites comprising a benzopinacol
US9221851B2 (en) Mixture containing a monophosphite ligand and the use thereof for catalysis of a hydroformylation reaction
US20160159718A1 (en) Monophosphites comprising an anthrol
US9212195B1 (en) Monophosphite ligands having a carbonate group
US11667657B2 (en) Diphosphites based on cis-butene-1,4-diol
US11027266B2 (en) Phosphorous acid P,P′-[5,5′,6,6′-tetramethyl-3,3′-bis(l- methylethyl)[1,1′-biphenyl]-2,2′-diyl] P,P,P′,P'-tetrakis(2,4-dimethylphenyl) ester in hydroformylation
US11560396B2 (en) Diphosphites having an open and a closed 2,4-methylated outer unit
US11618760B2 (en) Diphosphites with an open, 3-methylated outer unit
US9605010B2 (en) Monophosphite compounds having a methyl group
US20220056059A1 (en) 6,6'-([1,1'-biphenyl]-2,3'-diylbis(oxy))didibenzo[d,f][1,3,2]dioxaphosphepines

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION